We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Rheumatology

Journal Scan / Research · January 09, 2023

Predictors of Hypogammaglobulinemia in ANCA-Associated Vasculitis After Rituximab Induction Therapy

Rheumatology (Oxford, England)


Additional Info

Rheumatology (Oxford, England)
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study
Rheumatology (Oxford) 2022 Dec 23;[EPub Ahead of Print], MA Podestà, F Mescia, A Ricchiuto, R Smith, M Tedesco, MA Cassia, J Holle, RA Sinico, A Bruchfeld, I Gunnarsson, S Ohlsson, B Baslund, Z Hruskova, V Tesar, G Sabiu, M Gallieni, MC Cid, A Vaglio, L Harper, M Cozzolino, F Scolari, D Jayne, F Alberici

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading